Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)

CompletedOBSERVATIONAL
Enrollment

427

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

April 3, 2018

Study Completion Date

April 3, 2018

Conditions
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic ArthritisPsoriasisCrohn's DiseaseUlcerative Colitis
Interventions
BIOLOGICAL

Adalimumab

Pre-filled syringe or pen, administered by subcutaneous injection

BEHAVIORAL

AbbVie Care 2.0

Supportive services provided to participants included reminder calls, emails, text messages, nursing services, dietician, and psychological support. An adalimumab starter pack, injection guide, digital and print educational materials were also provided.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY